BRKR earnings

Bruker Corporation (NASDAQ:BRKR) today announced it will report first quarter 2026 financial results before market opening on Wednesday, May 6, 2026. The Company will host a conference call and webcast at 8:00 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q1 2026 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-4

Q4-25 revenues of $977.2 million, flat year-over-year (yoy), down ~5% organically Q4-25 GAAP diluted earnings per share (EPS) of $0.10; non-GAAP diluted EPS of $0.59 FY25 revenues of $3.44 billion, up ~2% yoy, down ~4% organically FY25 GAAP diluted loss per share of $(0.15); non-GAAP diluted EPS of $1.83 Bruker initiates FY26 guidance: Revenues of $3.57 to $3.60 billion, up 4% to 5% yoy, with organic growth of 1% to 2% Non-GAAP EPS of $2.10 to $2.15, up 15% to 17% yoy, including an ~8% FX headwind Bruker Corporation (NASDAQ:BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2025. Frank H. Laukien, Bruker's Presid

Bruker Corporation (NASDAQ:BRKR) today announced it will report fourth quarter and fiscal year 2025 financial results before market opening on Thursday, February 12, 2026. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q4 2025 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-43

Q3 2025 revenues of $860.5 million, down 0.5% year-over-year (yoy), down 4.5% organically Q3 2025 GAAP diluted loss per share $(0.41); non-GAAP diluted earnings per share (EPS) $0.45 Updated FY2025 guidance: Revenue $3.41 to $3.44 billion; reported growth of 1-2% yoy, organic decline of 4-5% Non-GAAP EPS $1.85 to $1.90   Bruker Corporation (NASDAQ:BRKR) today announced financial results for the three and nine months ended September 30, 2025. Frank H. Laukien, Bruker's President and CEO, commented: "In the third quarter, we were encouraged by our mid-single digit percentage organic bookings growth year-over-year, with a Scientific Instruments segment book-to-bill ratio

Bruker Corporation (NASDAQ:BRKR) today announced it will report third quarter 2025 financial results before market opening on Monday, November 3, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q3 2025 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1

Bruker Corporation (NASDAQ:BRKR) today announced preliminary revenue for the second quarter ended June 30, 2025 in a range of $795 - $798 million, which implies approximately flat reported revenue year-over-year. Bruker estimates that its non-GAAP organic revenue in the second quarter of 2025 declined approximately 7% year-over-year, with constant-exchange rate revenue declining approximately 3%. Second quarter 2025 bookings reflect weak academic demand, as well as softness in the U.S. biopharma market. Second quarter 2025 non-GAAP EPS is expected in the $0.32 - $0.34 range, representing approximately a $0.19 per share decline year-over-year, including a $0.06 foreign currency headwind.

 Q1 2025 revenues of $801.4 million, up 11.0% year-over-year; organic revenue up 2.9%, and constant-exchange rate (CER) revenue up 12.5%; Bruker Scientific Instrument (BSI) segment organic revenue up 5.1% Q1 2025 GAAP diluted EPS $0.11; non-GAAP diluted EPS $0.47, down 11.3% yoy on M&A headwinds Guidance on organic revenue and EPS adjusted for US policy changes and tariff headwinds. Updated FY 2025 guidance: Revenue $3.48 to $3.55 billion, up 3.5% to 5.5%, incl. organic growth of 0% to 2% Non-GAAP EPS $2.40 to $2.48, growth of 0% to 3% yoy Bruker Corporation (NASDAQ:BRKR) today announced financial results for its first quarter ended March 31, 2025. Frank H. Laukien, Bruker's

Bruker Corporation (NASDAQ:BRKR) today announced preliminary revenue for the first quarter ended March 31, 2025, in a range of $795 million to $800 million, comparing favorably to the Company's earlier outlook and well ahead of consensus. This estimated range implies reported revenue growth of approximately 10% year-over-year, with low-double digit percentage constant exchange rate revenue growth. Bruker estimates non-GAAP organic revenue growth in the first quarter to be in the low-single digit percentages, with mid-single digit percentage organic revenue growth in the Bruker Scientific Instrument (BSI) segment, and a high-teens percentage organic revenue decline in the BEST segment, net

Bruker Corporation (NASDAQ:BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q4 2024 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-43

Bruker Corporation (NASDAQ:BRKR) today announced it will report third quarter 2024 financial results before market opening on Tuesday, November 5, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q3 2024 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-

Q2 2024 revenues of $800.7 million, up 17.4% year-over-year (yoy); organic revenue up 7.4% yoy; CER revenue up 18.5% yoy Q2 2024 GAAP EPS $0.05; non-GAAP EPS $0.52, up 4.0% yoy Bruker increases FY 2024 revenue guidance to $3.38-$3.44 billion, now including the NanoString business; implies revenue growth of 14% to 16%, and organic revenue growth of 5% to 7% yoy Bruker Corporation (NASDAQ:BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2024. Frank H. Laukien, Bruker's President and CEO, commented: "Our teams delivered excellent revenue growth in the second quarter and a solid first half of 2024, despite soft general market condi

Bruker Corporation (NASDAQ:BRKR) today announced it will report second quarter 2024 financial results before market opening on Tuesday, August 6, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q2 2024 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1

Q1 2024 revenues of $721.7 million, up 5.3% year-over-year (yoy); organic revenue up 1.6% yoy, and constant-exchange rate (CER) revenue up 5.5% yoy Q1 2024 GAAP EPS of $0.35; non-GAAP EPS of $0.53 Updated FY 2024 guidance: Revenue $3.29 to $3.35 billion, up $60 million from prior guidance, implying reported growth of 11% to 13% yoy. Organic revenue growth maintained at 5% to 7% yoy CER revenue growth of 12% to 14% yoy, including closed Chemspeed and ELITech acquisitions, up from prior guidance of 8% to 10% yoy Non-GAAP EPS of $2.79 to $2.84, up $0.08 from prior guidance, including ELITech EPS accretion, but excluding still pending EPS-dilutive NanoString acquisition

Bruker Corporation (NASDAQ:BRKR) today announced it will report first quarter 2024 financial results before market opening on Thursday, May 2, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q1 2024 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-41

Q4 2023 revenues of $854.5 million, up 20.6% year-over-year (yoy); organic revenue up 15.9% yoy Q4 2023 GAAP EPS of $1.41, including a $0.99 per share gain on PhenomeX acquisition[1]; Q4 2023 non-GAAP EPS of $0.70, down 5.4% yoy; pro forma non-GAAP EPS excluding PhenomeX acquisition up 8.1% yoy Full year 2023 revenues of $2.96 billion, up 17.1% yoy; organic revenue growth of 14.5% yoy Full year 2023 GAAP EPS of $2.90; non-GAAP EPS of $2.58, up 10.3% yoy; pro forma non-GAAP EPS excluding PhenomeX acquisition up 14.5% yoy Bruker expects 2024 constant-exchange rate (CER) revenue growth of 8% to 10% yoy, including organic revenue growth of 5% to 7%. Bruker Corporation (NASDAQ

Bruker Corporation (NASDAQ:BRKR) today announced it will report fourth quarter and fiscal year 2023 financial results before market opening on Tuesday, February 13, 2024. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q4 2023 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437

Q3 2023 revenues of $742.8 million, up 16.3% year-over-year (yoy); organic revenue up 10.9% yoy Q3 2023 GAAP EPS $0.60; non-GAAP EPS $0.74, up 12.1% yoy Bruker increases FY 2023 revenue guidance to $2.88-$2.91 billion; implies reported revenue growth of 14%-15% yoy, and organic revenue growth of 11.5%-12.5% yoy, with organic growth up 150 bps at the midpoint vs. prior guidance Bruker Corporation (NASDAQ:BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2023. Third Quarter 2023 Financial Results Bruker's revenues for the third quarter of 2023 were $742.8 million, an increase of 16.3% compared to $638.9 million in the third

Bruker Corporation (NASDAQ:BRKR) today announced it will report third quarter 2023 financial results before market opening on Thursday, November 2, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q3 2023 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-833-470-1428 (U.S. toll free) wit

Q2 2023 revenues of $681.9 million, up 15.9% year-over-year (yoy); organic revenue up 13.5% yoy Q2 2023 GAAP EPS $0.39; non-GAAP EPS $0.50, up 11.1% yoy Bruker increases FY 2023 revenue guidance to $2.85-$2.90 billion; implies revenue growth of 12.5%-14.5%, and organic revenue growth at 9.5%-11.5% Bruker Corporation (NASDAQ:BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2023. Second Quarter 2023 Financial Results Bruker's revenues for the second quarter of 2023 were $681.9 million, an increase of 15.9% compared to $588.4 million in the second quarter of 2022. In the second quarter of 2023, revenues increased 13.5% organical

Bruker Corporation (NASDAQ:BRKR) today announced it will report second quarter 2023 financial results before market opening on Thursday, August 3, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q2 2023 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +

Q1 2023 revenues of $685.3 million, up 15.2% year-over-year (yoy); organic revenue up 17.6% yoy Q1 2023 GAAP EPS $0.52; non-GAAP EPS $0.64, up 30.6% yoy Bruker increases FY 2023 guidance for revenue to $2.83-$2.88 billion and for non-GAAP EPS to $2.55-$2.60; implies revenue growth to 12%-14%, and organic revenue growth of 9% - 11% yoy Bruker Corporation (NASDAQ:BRKR) today announced financial results for its first quarter ended March 31, 2023. First Quarter 2023 Financial Results Bruker's revenues for the first quarter of 2023 were $685.3 million, an increase of 15.2% compared to $595.0 million in the first quarter of 2022. In the first quarter of 2023, revenues increased 17.6

Bruker Corporation (NASDAQ:BRKR) today announced it will report first quarter 2023 financial results before market opening on Thursday, May 4, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q1 2023 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-41

Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy FY 2022 revenues $2.531 billion, up 4.7% yoy; organic revenue growth of 10.2% FY 2022 GAAP EPS $1.99; non-GAAP EPS $2.34, up 11.4% yoy Bruker expects FY 2023 organic revenue growth of 8% to 10% yoy Bruker Corporation (NASDAQ:BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2022. Fourth Quarter 2022 Financial Results Bruker's revenues for the fourth quarter of 2022 were $708.4 million, an increase of 3.6% compared to $683.5 million in the fourth quarter of 2021. In the fourt

Bruker Corporation (NASDAQ:BRKR) today announced it will report fourth quarter and fiscal year 2022 financial results before market opening on Thursday, February 9, 2023. The Company will host a conference call and webcast at 8:30 a.m. Eastern Standard Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q4 2022 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2

Q3 2022 reported revenue growth of 4.9% year-over-year (yoy); organic revenue growth of 12.7% Q3 2022 GAAP operating margin 20.6%; non-GAAP operating margin 22.4%, up 180 basis points yoy Q3 2022 GAAP EPS $0.59; non-GAAP EPS $0.66, up 4.8% yoy Given strong year-to-date performance and high backlog, Bruker is raising its FY 2022 guidance for organic revenue growth and non-GAAP operating margin expansion Bruker Corporation (NASDAQ:BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2022. Third Quarter 2022 Financial Results Bruker's revenues for the third quarter of 2022 were $638.9 million, an increase of 4.9% compared to $608.

Bruker Corporation (NASDAQ:BRKR) today announced it will report third quarter 2022 financial results before market opening on Thursday, November 3, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q3 2022 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1

Q2 2022 reported revenue growth of 3.1% year-over-year (yoy); organic revenue growth of 8.8% Q2 2022 GAAP EPS $0.33; non-GAAP EPS $0.45, up 2.3% yoy Maintaining FY 2022 guidance for high, single-digit organic revenue growth, non-GAAP operating profit margin expansion and non-GAAP EPS increase Bruker Corporation (NASDAQ:BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2022. Second Quarter 2022 Financial Results Bruker's revenues for the second quarter of 2022 were $588.4 million, an increase of 3.1% compared to $570.8 million in the second quarter of 2021. In the second quarter of 2022, revenues increased 8.8% organically year-over

Bruker Corporation (NASDAQ:BRKR) today announced it will report second quarter 2022 financial results after market close on Wednesday, August 3, 2022. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q2 2022 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-41

Q1 2022 revenue growth of 7.3% year-over-year (yoy); organic revenue growth of 10.5% Q1 2022 GAAP EPS $0.41; non-GAAP EPS $0.49, up 11.4% yoy Raising fiscal year 2022 organic revenue outlook on strong demand for the Company's high-performance life science tools, scientific instruments and diagnostic solutions Bruker Corporation (NASDAQ:BRKR) today announced financial results for its first quarter ended March 31, 2022. First Quarter 2022 Financial Results Bruker's revenues for the first quarter of 2022 were $595.0 million, an increase of 7.3% compared to $554.7 million in the first quarter of 2021. In the first quarter of 2022, revenues increased 10.5% organically year-over-year. Gr

Bruker Corporation (NASDAQ:BRKR) today announced it will report first quarter 2022 financial results before market opening on Wednesday, May 4, 2022. The Company will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q1 2022 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1-412

Q4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy FY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy Solid organic revenue and non-GAAP EPS growth expected in FY 2022, with significant investments in Project Accelerate 2.0 initiatives, particularly in proteomics, spatial biology, semicon metrology and biopharma Bruker Corporation (NASDAQ:BRKR) today announced financial results for its fourth quarter and for the fiscal year ended December 31, 2021. Fourth Quarter 2021 Financial Results Bruker's reve

Q3 2021 revenues of $608.9 million, up 19.1% year-over-year (yoy); organic growth of 17.8% Q3 2021 GAAP EPS of $0.57, up 63% yoy; non-GAAP EPS of $0.63, up 50% yoy Raising FY 2021 guidance significantly on strong demand for Bruker's products and solutions Bruker Corporation (NASDAQ:BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2021. Third Quarter 2021 Financial Results Bruker's revenues for the third quarter of 2021 were $608.9 million, an increase of 19.1% compared to revenues of $511.4 million in the third quarter of 2020. In the third quarter of 2021, revenues increased 17.8% organically year-over-year, growth from acqu

Bruker Corporation (NASDAQ:BRKR) today announced it will report third quarter 2021 financial results on Monday, November 1, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q3 2021 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +

Q2 2021 revenue growth of 34.4% year-over-year; organic revenue growth of 27.2% Q2 2021 GAAP EPS of $0.38; non-GAAP EPS of $0.44, compared to $0.21 in Q2 2020 Strong financial performance in the Bruker Scientific Instruments and BEST businesses drives a further increase in fiscal year 2021 guidance Bruker Corporation (NASDAQ:BRKR) today announced financial results for its second quarter and for the six months ended June 30, 2021. Second Quarter 2021 Financial Results Bruker's revenues for the second quarter of 2021 were $570.8 million, an increase of 34.4% compared to the second quarter of 2020. In the second quarter of 2021, revenues increased 27.2% organically year-over-year, gr

Bruker Corporation (NASDAQ:BRKR) today announced it will report second quarter 2021 financial results on Monday, August 2, 2021, after the market closes. The Company will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and current business trends. To listen to the webcast, investors can go to https://ir.bruker.com and click on the "Q2 2021 Earnings Webcast" hyperlink in the "Events & Presentations" section. A slide presentation will be referenced during the webcast and will be posted to the Company's website shortly before the webcast begins. Investors can also listen to the earnings webcast via telephone by dialing 1-888-437-2685 (U.S. toll free) or +1